Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapy drugs

A technology of IL-4R and chemotherapy drugs, applied in the field of chemotherapy drugs, to achieve the effect of enhancing sensitivity

Pending Publication Date: 2020-12-04
NANTONG UNIVERSITY
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention provides the application of IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapeutic drugs, and solves the technical problems in the prior art such as non-specific treatment drugs against IL-6

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapy drugs
  • Application of IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapy drugs
  • Application of IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapy drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Application of IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapeutic drug, said breast cancer chemotherapeutic drug is cisplatin.

[0052] IL-6R inhibitors are interleukin-6 (IL-6) receptor inhibitors, IL-4R inhibitors are interleukin-4 (IL-4) receptor inhibitors, and IL-4 is involved in promoting the M2 pole of macrophages. IL-6 is a pleiotropic cytokine with a wide range of functions. Both of them are involved in the regulation of the growth and differentiation of various cells. In the tumor microenvironment, IL-4 and IL-6 are involved in promoting the polarization of macrophages. In the late stage of tumor development, the two cooperate to promote the polarization of macrophage M2 and have anti-inflammatory effects.

[0053] The application of the polypeptide analogs in the treatment of breast cancer drugs, the steps are:

[0054] The first step is to establish an in vitro co-culture system of breast cancer cells and macrophages to simu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of an IL-6R inhibitor and IL-4R inhibitor combined drug in breast cancer chemotherapy drugs. IL-4 participates in promoting macrophage M2 polarization, IL-6 is a multi-effect cell factor with wide functions, and IL-4 and IL-6 participate in regulating growth and differentiation of various cells, have the functions of regulating immune response, acute phase reaction and hematopoiesis and play an important role in anti-infection immune response of the body. In the tumor microenvironment, IL-4 and IL-6 participate in promoting macrophage polarization, IL-4 andIL-6 synergistically act in the later stage of tumor development to promote macrophage M2 polarization, and IL-4 and IL-6 have an anti-inflammatory effect and can promote tumor development. The effectof the IL-6R inhibitor and IL-4R inhibitor combined drug in the breast cancer chemotherapy drugs is researched through the synergistic effect of the IL-6R inhibitor and IL-4R inhibitor.

Description

technical field [0001] The invention relates to the technical field of chemotherapeutic drugs, in particular to the application of IL-6R inhibitors and IL-4R inhibitors in breast cancer chemotherapy drugs. Background technique [0002] The immune system is a major player in crosstalk in the tumor microenvironment. Tumor-associated macrophages (TAMs), accounting for 50% of the total tumor mass, are the major population of immune cells that constitute the tumor microenvironment, with properties designed to promote tumor growth and angiogenesis, tissue remodeling and suppress adaptive immunity. Macrophages have high plasticity to various external signals and participate in innate and adoptive immune responses. Depending on the microenvironmental signals present, macrophages are polarized into two distinct phenotypes, classically activated (M1) or alternatively activated (M2) macrophages. Tumor-associated macrophages (TAMs) closely resemble polarized M2s. Clinicopathological ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K33/243A61P15/14A61P35/00A61P29/00
CPCA61K45/06A61K33/243A61P15/14A61P35/00A61P29/00A61K2300/00
Inventor 周佳敏王国华叶莉莎高纯一吴昊鲍海妮耿劲松
Owner NANTONG UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com